Human circadian system causes a morning peak in prothrombotic plasminogen activator inhibitor-1 (PAI-1) independent of the sleep/wake cycle

被引:125
作者
Scheer, Frank A. J. L. [1 ,2 ]
Shea, Steven A. [1 ,2 ,3 ]
机构
[1] Brigham & Womens Hosp, Div Sleep Med, Med Chronobiol Program, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA
基金
美国国家卫生研究院;
关键词
MYOCARDIAL-INFARCTION; FIBRINOLYTIC-ACTIVITY; RHYTHM; GENE; FLUCTUATIONS; OSCILLATION; COMPONENTS; EXERCISE; PROMOTER; BLOOD;
D O I
10.1182/blood-2013-07-517060
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Serious adverse cardiovascular events peak in the morning, possibly related to increased thrombosis in critical vessels. Plasminogen activator inhibitor-1 (PAI-1), which inhibits fibrinolysis, is a key circulating prothrombotic factor that rises in the morning in humans. We tested whether this morning peak in PAI-1 is caused by the internal circadian system or by behaviors that typically occur in the morning, such as altered posture and physical activity. Twelve healthy adults underwent a 2-week protocol that enabled the distinction of endogenous circadian effects from behavioral and environmental effects. The results demonstrated a robust circadian rhythm in circulating PAI-1 with a peak corresponding to similar to 6:30 AM. This rhythm in PAI-1 was 8-times larger than changes in PAI-1 induced by standardized behavioral stressors, including head-up tilt and 15-minute cycle exercise. If this large endogenous morning peak in PAI-1 persists in vulnerable individuals, it could help explain the morning peak in adverse cardiovascular events.
引用
收藏
页码:590 / 593
页数:4
相关论文
共 50 条
  • [1] Genetics of Plasminogen Activator Inhibitor-1 (PAI-1) in a Ghanaian Population
    White, Marquitta J.
    Kodaman, Nuri M.
    Harder, Reed H.
    Asselbergs, Folkert W.
    Vaughan, Douglas E.
    Brown, Nancy J.
    Moore, Jason H.
    Williams, Scott M.
    PLOS ONE, 2015, 10 (08):
  • [2] GENETIC-VARIATION AT THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) LOCUS
    DAWSON, S
    HAMSTEN, A
    WIMAN, B
    HENNEY, A
    HUMPHRIES, S
    FIBRINOLYSIS, 1990, 4 : 51 - 53
  • [3] Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatments
    Party, Helene
    Dujarrier, Cleo
    Hebert, Marie
    Lenoir, Sophie
    Martinez de Lizarrondo, Sara
    Delepee, Raphael
    Fauchon, Claudine
    Bouton, Marie-Christine
    Obiang, Pauline
    Godefroy, Olivier
    Save, Etienne
    Lecardeur, Laurent
    Chabry, Joelle
    Vivien, Denis
    Agin, Veronique
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2019, 7 (01)
  • [4] Design, synthesis, and SAR of embelin analogues as the inhibitors of PAI-1 (plasminogen activator inhibitor-1)
    Chen, Fanglei
    Zhang, Guiping
    Hong, Zebin
    Lin, Zhonghui
    Lei, Min
    Huang, Mingdong
    Hu, Lihong
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (10) : 2379 - 2382
  • [5] A Profibrotic Effect of Plasminogen Activator Inhibitor Type-1 (PAI-1) in the Heart
    Zaman, A. K. M. Tarikuz
    French, Christopher J.
    Schneider, David J.
    Sobel, Burton E.
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2009, 234 (03) : 246 - 254
  • [6] Circadian fluctuations in circulating plasminogen activator inhibitor-1 are independent of feeding cycles in mice
    Oishi, Katsutaka
    Ohkura, Naoki
    Yasumoto, Yuki
    Yamamoto, Saori
    CHRONOBIOLOGY INTERNATIONAL, 2017, 34 (02) : 254 - 259
  • [7] ROLE OF PLASMINOGEN ACTIVATOR INHIBITOR -1 (PAI-1) IN CANCER STEM CELLS
    Irmak-Yazicioglu, M. B.
    Ergun, K.
    WORLD CANCER RESEARCH JOURNAL, 2022, 9
  • [9] Differential regulation of the plasminogen activator inhibitor-1 (PAI-1) gene expression by growth factors and progesterone in human endometrial stromal cells
    Sandberg, T
    Eriksson, P
    Gustavsson, B
    Casslen, B
    MOLECULAR HUMAN REPRODUCTION, 1997, 3 (09) : 781 - 787
  • [10] Association between Five Common Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms and Colorectal Cancer Susceptibility
    Oh, Jisu
    An, Hui Jeong
    Kim, Jung Oh
    Jun, Hak Hoon
    Kim, Woo Ram
    Kim, Eo Jin
    Oh, Doyeun
    Kim, Jong Woo
    Kim, Nam Keun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 15